Tess Fries

Tess Fries is the inventor and founder of Elixira, a patent-pending nanobot platform designed 2025 for lifelong, autonomous cancer prevention. She is also the founder of Nanoism, a medical discipline in preventive medicine that focuses on autonomous, lifelong prevention through the integration of nanotechnology, artificial intelligence, and self-powered nanoscale systems.

Key publications:

Fries, T. (2025). Elixira: A Feasibility Framework for AI-Guided Nanomedicine in Cancer Prevention. [White paper] Zenodo. https://doi.org/10.5281/zenodo.16970549

Fries, T. (2025). Nanoism: The Emergence of a New Medical Field in Preventive Medicine. [White paper] Zenodo. https://doi.org/10.5281/zenodo.16990051

Fries, T. (2025). Elixira: A Multidisease Prevention Platform – Evolving the Future of Lifelong Preventive Medicine. [White paper] Zenodo. https://doi.org/10.5281/zenodo.17014474

Fries, T. (2025). Elixira: Inside the World's First Autonomous Cancer Prevention Platform. [White paper] Zenodo. https://doi.org/10.5281/zenodo.17039107

With a focus on bridging nanotechnology, biotechnology, and AI, Tess is dedicated to creating transformative healthcare solutions that transcend preventive medicine. Her vision is to accelerate the transition towards a world where advanced technology and ethics work hand in hand to eliminate disease and extend human health.